{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:30:30Z","timestamp":1763037030306,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","explorejournal.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EXPLORE"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.explore.2016.10.007","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T17:30:51Z","timestamp":1477071051000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Reports of Idiopathic Thrombocytopenia Unresponsive to First-Line Therapies Treated With Traditional Herbal Medicines Based on Syndrome Differentiation"],"prefix":"10.1016","volume":"13","author":[{"given":"Juno","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-1175","authenticated-orcid":false,"given":"Beom-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.explore.2016.10.007_bib1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.explore.2016.10.007_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.explore.2016.10.007_bib3","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.explore.2016.10.007_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s00464-005-0445-6","article-title":"Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura","volume":"20","author":"Balagu\u00e9","year":"2006","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.explore.2016.10.007_bib5","first-page":"2","article-title":"Primary immune thrombocytopenia in adults","volume":"4","author":"Janssens","year":"2013","journal-title":"Belg J Hematol"},{"issue":"9","key":"10.1016\/j.explore.2016.10.007_bib6","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.explore.2016.10.007_bib7","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1182\/blood-2012-12-467068","article-title":"Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia","volume":"121","author":"Boyle","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.explore.2016.10.007_bib8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood-2011-12-309153","article-title":"How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment","volume":"120","author":"Ghanima","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.explore.2016.10.007_bib9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3324\/haematol.2011.055830","article-title":"Immune thrombocytopenia in children and adults: what\u05f3s the same, what\u05f3s different?","volume":"96","author":"Schulze","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.explore.2016.10.007_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jep.2012.01.033","article-title":"Syndrome differentiation in modern research of traditional Chinese medicine","volume":"140","author":"Jiang","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"10.1016\/j.explore.2016.10.007_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11655-011-0890-0","article-title":"A systematic analysis of the theory and practice of syndrome differentiation","volume":"17","author":"Mei","year":"2011","journal-title":"Chin J Integr Med"},{"issue":"2","key":"10.1016\/j.explore.2016.10.007_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jep.2011.08.045","article-title":"An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis","volume":"141","author":"Lu","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"10.1016\/j.explore.2016.10.007_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3736\/jcim20040605","article-title":"Clinical study on idiopathic thrombocytopenic purpura treated with Shengxueling Granule","volume":"2","author":"Zhou","year":"2004","journal-title":"J Chin Integr Med"},{"issue":"1","key":"10.1016\/j.explore.2016.10.007_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11655-007-0033-9","article-title":"Treatment of 37 patients with refractory idiopathic thrombocytopenic purpura by Shengxueling","volume":"13","author":"Shao","year":"2007","journal-title":"J Chin Integr Med"},{"issue":"5","key":"10.1016\/j.explore.2016.10.007_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ctim.2013.08.005","article-title":"Alternative therapy for persistent childhood immune thrombocytopenic purpura unresponsive to intravenous immunoglobulin","volume":"21","author":"Huang","year":"2013","journal-title":"Complement Ther Med"},{"issue":"4","key":"10.1016\/j.explore.2016.10.007_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2014.01.026","article-title":"Diagnosis and classification of immune-mediated thrombocytopenia","volume":"13","author":"Lo","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.explore.2016.10.007_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports","volume":"85","author":"Terrell","year":"2010","journal-title":"Am J Hematol"},{"issue":"9299","key":"10.1016\/j.explore.2016.10.007_bib18","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(01)07219-1","article-title":"Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study","volume":"358","author":"K\u00fchne","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.explore.2016.10.007_bib19","first-page":"79","article-title":"Early prediction of chronic childhood immune thrombocytopenic purpura according to the response of immunoglobulin treatment","volume":"20","author":"Uk Hyun","year":"2013","journal-title":"Clin Pediatr Hematol Oncol"},{"key":"10.1016\/j.explore.2016.10.007_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0609.2007.01000.x","article-title":"First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat","volume":"80","author":"Rodeghiero","year":"2008","journal-title":"Eur J Haematol"},{"issue":"04","key":"10.1016\/j.explore.2016.10.007_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0034-1544001","article-title":"Can Immune thrombocytopenia be cured with medical therapy?","volume":"41","author":"Cuker","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"4 Pt 2","key":"10.1016\/j.explore.2016.10.007_bib22","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.lpm.2014.02.010","article-title":"Immune thrombocytopenic purpura: major progress in knowledge of the pathophysiology and the therapeutic strategy, but still a lot of issues","volume":"43","author":"Godeau","year":"2014","journal-title":"Presse M\u00e9d (Paris, France: 1983)"},{"issue":"2","key":"10.1016\/j.explore.2016.10.007_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Marieke Schoonen","year":"2009","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.explore.2016.10.007_bib24","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","article-title":"Vascular complications after splenectomy for hematologic disorders","volume":"114","author":"Crary","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.explore.2016.10.007_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.thromres.2007.12.022","article-title":"Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP","volume":"122","author":"Fontana","year":"2008","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.explore.2016.10.007_bib26","first-page":"233","article-title":"Long-term observation of 87 cases with chronic idiopathic thrombocytopenic purpura in adults","volume":"35","author":"Kyung Soon","year":"2000","journal-title":"Korean J Hematol"},{"issue":"2","key":"10.1016\/j.explore.2016.10.007_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12185-011-0894-8","article-title":"Chronic adult primary immune thrombocytopenia (ITP) in the Asia\u2013Pacific region","volume":"94","author":"Heng","year":"2011","journal-title":"Int J Hematol"},{"issue":"11","key":"10.1016\/j.explore.2016.10.007_bib28","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.explore.2016.10.007_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0609.2008.01208.x","article-title":"Immune thrombocytopenic purpura: the treatment paradigm","volume":"82","author":"Stasi","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.explore.2016.10.007_bib30","first-page":"1","article-title":"Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim","author":"Bussel","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.explore.2016.10.007_bib31","first-page":"038","article-title":"Examination of Chinese medicine treatment of idiopathic thrombocytopenic purpura","volume":"5","author":"Chu","year":"2012","journal-title":"China J Tradit Chin Med Pharm"},{"issue":"2","key":"10.1016\/j.explore.2016.10.007_bib32","first-page":"77","article-title":"Refractory idiopathic thrombocytopenic purpura: an integrated approach to treatment","volume":"18","author":"Hoang","year":"2003","journal-title":"J Orthomol Med"},{"key":"10.1016\/j.explore.2016.10.007_bib33","first-page":"008","article-title":"Clinical observation of therapy involving dispelling wind, cooling the blood, and tonifYing the kidney for refractory idiopathic thrombocytopenic purpura","volume":"6","author":"Chen","year":"2008","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"issue":"4","key":"10.1016\/j.explore.2016.10.007_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0254-6272(12)60004-1","article-title":"Multi-central clinical research into treating 80 cases of chronic thrombocytopenia with Qi-supplementing and Yin-nourishing therapy and Western medicine","volume":"31","author":"Zhou","year":"2011","journal-title":"J Tradit Chin Med"}],"container-title":["EXPLORE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550830716301665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550830716301665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T03:28:43Z","timestamp":1718854123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550830716301665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1550830716301665"],"URL":"https:\/\/doi.org\/10.1016\/j.explore.2016.10.007","relation":{},"ISSN":["1550-8307"],"issn-type":[{"type":"print","value":"1550-8307"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case Reports of Idiopathic Thrombocytopenia Unresponsive to First-Line Therapies Treated With Traditional Herbal Medicines Based on Syndrome Differentiation","name":"articletitle","label":"Article Title"},{"value":"EXPLORE","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.explore.2016.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}